Skip to main content
Equibles

NORGES BANK

Bank

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 1374170 OSLO, Q8
Back to RXRX Full portfolio

Position in RXRX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$25,079,069
+$1,606,298 QoQ
Shares Held
6,833,534
+19.1% QoQ
Ownership
1.28%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 344 holders
Holding Since
Jun 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RXRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NORGES BANK holds $7,365,469,141 across 55 Biotechnology names. RXRX ranks #32 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,971,681 $1,476,123,103
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,172,808 $731,292,700
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,271,813 $683,883,867
4 BMRN
Biomarin Pharmaceutical Inc
 8,207,954 $469,659,127
5 RVMD
Revolution Medicines, Inc.
 2,157,479 $404,052,667
6 INSM
INSMED Inc
 3,377,641 $360,124,083
7 ARWR
Arrowhead Pharmaceuticals, Inc.
 3,896,536 $317,606,649
8 RPRX
Royalty Pharma plc
 5,336,084 $299,194,229

All Filings in RXRX

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $25,079,069 6,833,534
2025-12-31 $23,472,771 5,739,064
2025-06-30 $16,039,886 3,169,938
2025-03-31 $18,049,495 3,412,003
2024-12-31 $23,429,315 3,465,875
2024-09-30 $23,543,144 3,572,556
2024-06-30 $14,604,712 1,947,295
2024-03-31 $31,630,243 3,172,542
2023-12-31 $34,825,165 3,531,964
2023-09-30 $26,210,858 3,426,256
2023-06-30 $21,418,118 2,867,218
2023-03-31 $28,187,993 4,226,086
2022-12-31 $33,702,823 4,371,313
2022-09-30 $46,510,770 4,371,313
2022-06-30 $34,638,198 4,255,307
2022-03-31 $10,004,489 1,397,275
2021-12-31 $23,935,303 1,397,274
2021-09-30 $11,505,000 500,000
2021-06-30 $18,250,000 500,000